Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 27, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

September 26, 2017

Conditions

Healthy

Interventions

BIOLOGICAL

PF-06823859

Comparison of different dosages of PF-06823859 to placebo

DRUG

Placebo injection SC/IV

Comparison of Placebo to different doses of PF-06823859

Trial Locations (1)

Pfizer New Haven Clinical Research Unit, New Haven